Allowability of intermediate generalisations: Be careful what you wish for

Reading time: 13 minutes

I have attended the EPO’s online conference Boards of Appeal and key decisions 2022 earlier this week. Highly interesting, as always. My personal highlight was the second day when the focus was on Art. 123(2) EPC (added matter):

Program of the second day

Oliver RANDL (I am still yearning for his K’s law blog) gave a brilliant presentation to set the stage on Art. 123 EPC in general, followed by a panel discussion about intermediate generalisations. Of particular interest from a Swiss perspective and in view of proceedings at the FPC: Tobias BREMI sat on that panel.

Here are my take-home messages and some food for further thought.

Article 123(2) EPC — Musings on a golden oldie

Oliver RANDL’s general presentation on Art. 123 EPC was fantastic. His talk was entertaining, thrilling and with clear messages of practical relevance. The most important one, in my view: Forget about all those dubious tests like the ‘novelty test’, the ‘essentiality test’, etc. What matters is the gold standard.

On the fun side, he taught me that I am running a freak show here:

Case law blogs are freak shows!

So, take good care of how to make use of all this … 😉

The Ringling Bros. lineup in 1924
Intermediate generalisations: Views from national judges and board members

Allowability of intermediate generalisations is getting quiete some attention in recent times. Graham MURNANE gave a good summary in epi Information 1/2022: Intermediate Generaliations — a review. The topic is dealt with in the EPO Guidelines (2022), chapter H-V, 3.2.1; and the Case Law of the Boards of Appeal (2022), chapter II.E.1.9.

The panel discussion of Giovanni PRICOLO (EPO), Tobias BREMI (CH) and Sir Richard ARNOLD (U.K.) was moderated by Wolfgang SEKRETARUK (EPO).

All three panelists presented a decision from their respective jurisdictions; red indicates an inadmissible intermediate generalisation, green an admissible amendment (I am referring to the latter only as an amendment and not as an intermediate generalisation for reasons that will become clear later):

    1. EPO: T 0879/18;
    2. Switzerland: 4A_11/2022 (Supreme Court) on appeal against O2019_007 of the Swiss FPC; and
    3. U.K.: Vector v Glatt, [2007] EWCA Civ 805

Let’s have a closer look at these three cases.

Giovanni PRICOLO introduced the EPO case: T 0879/18 (HTML | PDF). Indeed, I find that this decision is a very exhaustively and well reasoned example (spanning about 7.5 pages) of how the Boards typically assess allowability of intermediate generalisations; ¶4. I have no issue with it, really.

What is remarkable, though, is the Board’s note in ¶4.14: Mere boilerplate language to the effect that some shown features are optional is of no avail. Not much of a surprise, in my view.

The appearance of the Swiss case made my blood run cold because I was involved in that case and advocated with full conviction that the amendment added matter / was inadmissble. Without success. It’s okay, I’m over it. But since this case unexpectedly popped up again, here is the factual setup, in brief:

Slide Tobias BREMI

It was all about the feature «exposure to repeated and intense illumination»: It was part of the independent claim as filed (but not included anymore in the claim as granted (see the box at the bottom of the slide), and it was consistently also part of the most general introduction of the method of the invention in the specification. The box at the top of the slide is an abridged version of that disclosure; here is the full paragraph (recited in the FPC’s judgment):

This section requires that the detection step (singular, i.e. a single one) includes repeated and intense illumination. In my view, the terms repeated and intense are broad, but they are not just meaningless.

The claim as granted pretty much resembled the wording of the box in the middle, which is introduced in the general specification as «a preferred embodiment» of «the» method. Clearly, the argument was that this preferred embodiment carries all the limitations of the more general definition of the method with it, and that omission of «exposure to repeated and intense illumination» was an unallowable intermediate generalisation.

The FPC did not buy into this. But it is important to note at which point the argument failed. The FPC held two things in ¶57 of the judgment: (1.) What is described in the specification as a «preferred embodiment» (the box in the middle of the slide) would actually be understood by the skilled person in the case at hand as a standalone definition of the invention; and (2.) the feature would be implicit anyway / read along by the skilled person (‘liest der Fachmann […] implizit im erteilten Anspruch mit’).

Accordingly, and I’m really trying hard to be objective here, the FPC did not rule on the conditions under which an intermediate generalisation is admissible. Rather, the FPC held there was no intermediate generalisation at all. I do not believe that this decision is of much help to learn anything about whether or not the current approach of the FPC to admissibility of intermediate generalisations is more liberal than, e.g., the EPO’s approach.

At the appeal stage, the Supreme Court did not add much. The judgment simply holds that the FPC cannot be accused of a violation of the law if it did not simply apply linguistic logic:

Der Vorinstanz ist keine Rechtsverletzung vorzuwerfen, wenn sie es im Rahmen ihrer Prüfung der Offenbarungen nicht bei sprachlogischen Elementen bewenden liess; […].

Well, this is nothing new under the sun. What matters is the skilled person’s understanding: What is directly and unambiguosly disclosed? It is self-evident that this assessment cannot be a purely linguistic exercise. In any event, the Supreme Court doesn’t say anything about intermediate generalisations here.

To complete the picture from a Swiss perspective: It is not that there is no relevant case law on intermediate generalisations. In litigation between BD and Ypsomed, the Supreme Court clarified only recently that it is fully aligned with the jurisprudence of the Boards of Appeal in this respect:

The Supreme Court took note of some criticism e.g. by Stephan FREISCHEM in GRUR 2021, pp. 188-191 (‘[D]ie schleichende Enteignung der Erfinder’); see this Blog here. (I do like catchy titles myself. But I really don’t see the analogy with expropriation. Sorry not sorry; see below.) But it stood firm, and I could not agree more in this respect.

Moving on to the U.K.: Sir Richard ARNOLD presented Vector v Glatt, [2007] EWCA Civ 805. Back in the days, Richard ARNOLD was acting as QC for Vector, and he successfully argued that the claim at stake was a ‘true unallowable intermediate generalization.” ¶34. I have no issue with this decision.

My two cents

Art. 123(2) EPC provides that

[t]he European patent application or European patent may not be amended in such a way that it contains subject-matter which extends beyond the content of the application as filed.

Now, what is the ‘content of the application as filed’? The case-law of the Boards of Appeal is well established in this respect (Case Law of the Boards of Appeal, ed. 2022, II.E.1.3.1):

[W]hat a skilled person would derive directly and unambiguously, using common general knowledge, and seen objectively and relative to the date of filing, from the whole of these documents as filed (G 3/89, OJ 1993, 117; G 11/91, OJ 1993, 125; G 2/10, OJ 2012, 376, referring to this test as “gold standard”).

The EPO is renown for its strict approach on this, and we all struggle with it once in a while. But the EPO applies it consistently in the assessment of novelty, allowability of amendments, etc. Rightly so. Otherwise, we would get on a very slippery slope.

I am fully aware that my position may well be unpopular. But I am convinced that the EPO’s approach of allowability of intermediate generalisations is anything but overly restrictive. In fact, it is even borderline generous in more than just some cases.

Here is why.

The ‘content of the application as filed’ under Art. 123(2) EPC and the content of a prior art document in the assessment of novelty, Art. 54 EPC, need to be measured against the standard. There is no dispute about this, I believe.

Intermediate generalisations are always about the omission of features from a certain piece of dislosure, e.g., a specific embodiment outlined in the specification. The same situation may occur in the assessment of novelty over a prior art reference. Just think of a patent that claims a scissor, as follows:

Scissor with [A], [B] and [C], characterized in that it does not comprise a coating [D].

In opposition, a product leaflet of a scissor is cited as prior art. The scissor has features [A], [B], [C] —  and a coating [D]. No indication or explanation why the coating [D] is there, but it no doubt is there. Clearly, the claim is novel. I trust this is common ground.

Now, assume that the opponent additionally cites the ‘Handbook of Scissors’, and let’s further assume that this handbook is part of the skilled person’s common general knowledge. What if this handbook said: You may have a coating [D] on a scissor in order to improve cutting of X; and you better omit that coating [D] in order to improve cutting of Y? Does that change anything about the disclosure of the product leaflet? No, it doesn’t. There simply is a coating [D] in the leaflet, and it cannot be argued away by invoking common general knowledge. Whether or not that coating [D] could be omitted on the scissor disclosed in the leaflet in order to improve cutting of Y is an issue to be dealt with in the assessment of obviousness. There is just no way that the skilled person’s general knowledge can change the direct and unambiguous teaching of the leaflet. I trust that this is also common ground.

Now, why should it be any different in the assessment of intermediate generalisations? Why should an applicant be allowed to claim a scissor with only features [A], [B] and [C] based on an embodiment that undoubtedly discloses the same only in connection with a coating [D]? I am convinced that, as a rule, this should not be allowed. Exceptionally, it might be allowed when there is a clear and unambiguous teaching in the application as a whole that leaves no doubt about the fact that coating [D] was meant to be an option in the specific embodiment. If there is a remark in the general part of the specification that says coatings may or may not be there, that may well be sufficient basis for getting rid of coating [D] in the specific embodiment and to only claim [A], [B] and [C]. However, in the absence of such an overriding teaching, and even if the coating [D] is totally unrelated to the actual invention and when there is no apparent reason why it is there, it cannot be just disregarded. Very similar to the situation with the scissor leaflet: The coating is there. We may not know why, and we should not care. Any guesswork (even with the help of standard textbooks / common general knowledge) about whether it could be omitted in the context of the invention is misplaced.

Btw, Stephan FREISCHEM referred to T 1906/11 (hn; ¶4.2) as a promising example to get it better (if not even right):

In my mind, this decision is actually nothing out of the ordinary. The hn simply explains what the gold standard is all about. On the merits, the decision is telling: What carried the day for the patentee was the mentioning in the general part of the specification that the invention worked with essentially any electrode; see ¶4.2.4. Accordingly, that gave some leeway in order to allow an intermediate generalisation with respect to the electrode. I agree with that approach, as outlined above. It is already on the generous side.

Sorry not sorry

As a rule, there is no reason to have mercy with applicants when it comes to the assessment of allowability of intermediate generalisations, and they should not have the benefit of doubt: The application as filed is their own work product!

mad about me

We all make mistakes, and one is always wiser after the fact. (Oh man, you can’t even imagine how mad I was at myself already, more than once!) But I cannot understand callings for changes of practice / jurisprudence in order to not run into such trouble. Getting it right from the very beginning is key, i.e., when drafting the application as filed.

In my mind, drafting patent applications is the most underrated part of the work of us patent attorneys, and quite some applicants are (very) price sensitive in particular when it comes to drafting work, for some strange reason. There will always be someone who does it for less money, no doubt about it. Fair enough. But when the work product fails later on, and when it turns out that less money meant cheap, that’s first and foremost something for the client and the drafting attorney to discuss. You can only pick two. One may be symphathetic with the applicant / patentee suffering in such a situation. But this is no good reason for the EPO or judges to be lenient and to let the reins slip.

The gold standard about direct and unambiguous disclosure is a key metric of the whole jurisprudence of the Boards of Appeal in so many aspects, it is almost sacrosanct. It should be touched only with a very trembling hand (if at all), and definitely not without an overriding need to do so. I really fail to see such an overriding need in the assessment of intermediate generalisations.

Be careful what you wish for just in order to make the work of a drafting attorney a little easier; it might blow the whole system.

✍ MW

BE ON THE KNOW

Enter your name and email address below to get notified of new posts by email.

Not to be missed: The annual evening seminar about case-law of the FPC with Tobias Bremi

vespa.swiss

Don’t miss VESPA‘s evening seminar about recent case law of the FPC on Thu, 22 September 2022 in Zurich (17:15 hrs CEST); see the detailed program below.

Gain first-hand insight from Tobias BREMI (second ordinary judge at the FPC) at Haus zum Rüden, Limmatquai 42, 8001 Zurich; see map.

Even though there are no Covid-19 limitations currently in place, it’s a mixed mode event: You may also join the event by videoconference. But honestly, I can think of only a few very serious reasons for preferring not to meet your colleagues live in Zurich — unlike the dubious EPO practice to still require serious reasons for not holding oral proceedings by videoconference (sorry, I couldn’t help myself).

The event is free of charge for VESPA member; the fee for non-member is CHF 90,–. An apéro riche afterwards is offered for CHF 60,–.

Please use the registration form below or save your spot online.

Reported by Martin WILMING

PROGRAM

REGISTRATION FORM

MAP

BE ON THE KNOW

Enter your name and email address below to get notified of new posts by email.

Next ‘Fireside Chat’ on Wed, 29 June 2022, 12:15 CEST on LinkedIn

Reading time: 2 minutes
LinkedIn

It’s already close to the end of the month again, i.e. the next ‘Fireside Chat’ is upcoming. It will be the 15th edition, and it will be on LinkedIn for the second time. The switch from Clubhouse to LinkedIn Live worked smoothly — at least for me; I do hope, for you, too! If you missed it: The recordings of #14 are still available here.

The next ‘Fireside Chat’ is planned as follows:

Date: Wed, 29 June 2022
Time: 12:15 hrs CEST
Venue: LinkedIn; see you here

My current draft list of topics is as follows:

👉 S2022_002
Novartis ./. Mepha Pharma
Order of 2 June 2022: ‘Fingolimod 0.5 mg’
👉 O2020_004 (the aftermath)
yodoba AG ./. Swisscom (Schweiz) AG
Rumour has it …
👉 INGRES
Some take-aways from the GA of 23 June 2022

/MW

UPDATE 29 June 2022: Just in case you missed the live session: The recording is still available on LinkedIn. For the podcast lovers, an audio-only version is available here. Apologies, again, for the technical glitches in the beginning when starting the streaming engine.

BE ON THE KNOW

Enter your name and email address below to get notified of new posts by email.

Next ‘Fireside Chat’ on Wed, 1 June 2022, 12:15 CEST on LinkedIn

Reading time: 2 minutes
LinkedIn

I was re-thinking the Fireside Chat format a while ago, and I have been curious to learn how you would like it. The outcome of my little poll showed a clear tendency: A preference for lunch time over the evening; and a preference for LinkedIn Live over Clubhouse.

Accordingly, the next Fireside Chat is planned as follows:

Date: Wed, 1 June 2022
Time: 12:15 hrs CEST
Venue: LinkedIn; see you here

I hope the start time leaves you enough time to grab a sandwich before joining … 😉

My current draft list of topics is as follows:

👉 S2022_001
Pelliheat AG ./. Hans SCHÄREN
Judgment of 2 March 2022: ‘Register ban’
👉 O2020_004
yodoba AG ./. Swisscom (Schweiz) AG
Judgment of 22 March 2022: ‘Swisscom TV 2.0’
👉 S2021_006
Bayer HealthCare LLC ./. Helvepharm AG
Judgment of 26 April 2022: ‘Sorafenib tosylate’
👉 The FPC’s 10th Anniversary
Symposium of 6 May 2022: A quick recap
👉 Art. 84 EPC
Claims shall «be supported by the description» …
Missed the Live session? Here is the recording.

/MW

BE ON THE KNOW

Enter your name and email address below to get notified of new posts by email.

The Swiss FPC’s tenth anniversary: Eager for the next decade(s)!

Reading time: 5 minutes

Have you been at the symposium in St. Gallen last Friday, at the occasion of the Swiss FPC’s tenth anniversary? Oh man, what a great event that was! I am still quite inspired by the interesting discussions on the merits — and the joyful chats with so many colleagues, live and vibrant again.

I did not take sufficient notes in order to come up with a thorough summary of the whole day. The following are just some of my very personal take-away messages:

Since the beginnings of the FPC, a total of 56 judgments have been appealed to the Supreme Court; only nine appeals have been allowed, fully or in part. Such a 16 percent reversal rate is indicative of the (very) good quality of the first instance judgments of the FPC.

Some discussions circled around the disposal of cases by settlement. Dieter BRÄNDLE referred to it as the finest way of concluding a case («edelste Variante der Streitbeilegung»), for good reasons. However, settlements have become pretty rare in recent years; see the statistics here. This is most likely due to the fact that many cases are just tiny puzzle pieces in multi-jurisdictional patent fights which are not easily settled. Some courts do apply «shuttle diplomacy» in their settlement efforts (sometimes confused with «Einzelabreibungen», i.e. anything but truly diplomatic approaches to push / threaten the parties into a settlement). But it became very clear that the FPC will not try «shuttle diplomacy» in the near future.

The «Saisie Helvétique», a precise description of a presumably infringing embodiment, has not been used very often in more recent times. Why is that? Some said that parties might opt for a PI right away, instead of securing (further) evidence of the last tiny bit of infringment beforehand. Further, a precise description is anyting but cheap, and there may well be other options in particular in an international setup which are more favorable to secure evidence (e.g. a saisie-contrefaçon in France).

On the procedural side, it was discussed whether it should be possible for a plaintiff to base a PI request on the patent in suit in various versions, i.e. with a whole cascade of auxiliary inter partes limitations — or whether that inherently contravenes the necessary urgency. Indeed, I feel it may sometimes be a wise approach in PI proceedings to envoke the patent only to the extent necessary to precisely cover the attacked embodiment; one may still pursue the case more broadly in subsequent main proceedings anyway when time is not so much of the essence anymore (with a PI in place). It will be interesting to see how the FPC will henceforth deal with (too?) many inter partes limitations in PI proceedings.

On the merits, we discussed whether it is (or should be?) possible to just disregard a particular piece of prior art as closest prior art in the assessment of obviousness right away (simply because it is too unrelated to the invention), or whether anything has to be assessed in civil proceedings simply because a party pleaded it. It appears that this question had never been critical in judgments of the FPC by now; but it is still important to know that there is no settled case-law in this respect (see this Blog here).

Further, we briefly touched the formulation of the ‘objective technical problem’ and whether the ‘Swiss finish’ in some judgments is appropriate, i.e. that the problem should be somehow addressed in the closest prior art. See this Blog here for a more detailed discussion of this issue.

Oh, and one should maybe keep this pointed remark of Sir Colin BIRSS in mind when discussing a controversial judgment:

If you ever felt that arguing / pleading a case is difficult; believe me, judging that case is harder.

With respect to the UPC, it became clear that quality of its judgments will be the (most) critical issue for users. Anyway, the UPC will have to deal with this well-known triangle just like any other service provider:

service triangle

The UPC’s goal of 12m for main proceedings was considered as very (unrealistically?) ambitious. Quality will largely depend on the judges; the hiring is currently underway. The goal is to have not too many judges in the beginning (only 50 technically trained judges), both for cost reasons and to ensure that the judges have enough cases to gain experience.

Re opting-out, Beat WEIBEL of Siemens provided some statistical insight: They will opt out for 17.3% of Siemens’ entire portfolio.

The initially published version of the above paragraph erroneously mentioned an opt-out ratio of 12.7%. I confused my notes. The paragraph has been corrected; the correct value is 17.3%

/MW

PROGRAM

BE ON THE KNOW

Enter your name and email address below to get notified of new posts by email.

Buzzkills in the patenting of medical devices: Learn more at VESPA’s evening seminar on 14 April 2022 (mixed mode)

Just in case you missed it: VESPA’s next evening seminar is about patenting of medical devices, and in particular certain buzzkills one might come across in this respect:

«Spassbremsen» bei der Patentierung von Medizinprodukten

VESPA

The event will take place on Thursday, 14 April 2022 at the Haus zum Rüden in Zürich (see map). You may also attend online.

The detailed program and a registration form is available below.

And you know what’s best? Participation is free of charge for VESPA members (CHF 90,– for non-members). An apéro riche is offered after the seminar (CHF 60,–).

/MW

PROGRAM

REGISTRATION

MAP

BE ON THE KNOW

Enter your name and email address below to get notified of new posts by email.

Final call for the annual FPC case-law seminar on March 22 (mixed mode)

AROPI

Hurry up, it is still possible to sign up for the nineth edition of the joint AROPIVESPA seminar

The jurisprudence of the Federal Patent Court in 2021

VESPA

on Tuesday, 22 March 2022 at the Alpha-Palmiers hotel, rue du Petit-Chêne 34, 1003 Lausanne. You may also attend online.

Ralph Schlosser and Christophe Saam will present the legal and technical aspects of the decisions rendered by the Federal Patent Court in 2021, followed by a discussion.

Participation is free of charge for members of AROPI or ACBSE.

/MW

PROGRAM

18:15 hrs Opening connection
18:30 hrs Welcome / Introduction
18:40 hrs Presentation of the case-law
19:40 hrs Discussion
20:00 hrs Aperitif

REGISTRATION

Please sign-up for the event by Email to Olivier Sacroug, olivier@sacroug.ch

MAP

BE ON THE KNOW

Enter your name and email address below to get notified of new posts by email.

The Swiss FPC’s tenth anniversary: Don’t miss the symposium on 6 May 2022

Time flies. Ten years have now already passed since the Federal Patent Court became operational. Time to look back, to reflect, and to take a sneak peek into the future.

Towards this end, the FPC is organizing a not-to-be-missed symposium on Friday, 6 May 2022 in St. Gallen:

Europäisch harmonisiertes Patentrecht und nationale Patentgerichte: Rückblick und Ausblick

Please see the detailed program below for further information. Registration via an online form is open until 18 March 2022.

Oh, btw, it will be an in-person event. Real people meeting real people again, at a great location … 🙂

Reported by Martin WILMING

PROGRAM

REGISTRATION FORM

Please register online here.

MAP

BE ON THE KNOW

Enter your name and email address below to get notified of new posts by email.

The annual evening seminar about case-law of the FPC is back, in mixed mode!

vespa.swiss

Don’t miss VESPA‘s evening seminar about recent case law of the FPC on Thursday, 14 October 2021 in Zurich (17:15 hrs CET); see the detailed program below.

Gain first-hand insight from Tobias BREMI (second ordinary judge at the FPC) at Haus zum Rüden, Limmatquai 42, 8001 Zurich; see map. A covid certificate (3G) is required for attending the seminar in person.

But:
You may also join the event by videoconference.

The event is free of charge for VESPA member; the fee for non-member is CHF 90,–. An apéro riche afterwards is offered for CHF 60,–.

Please use the registration form below or save your spot online.

Reported by Martin WILMING

PROGRAM

REGISTRATION FORM

MAP

BE ON THE KNOW

Enter your name and email address below to get notified of new posts by email.

Book Launch Webinar: The Protection of Intellectual Property Rights Under International Investment Law

Klopschinski et al.

I recently came across the monograph ‘The Protection of Intellectual Property Rights Under International Investment Law‘, authored by Simon Klopschinski, Christopher Gibson and Henning Grosse Ruse-Khan. It has been published in December 2020, and a review has been published on The IPKat about a month ago.

The reason why I am mentioning this here is that there will be a book launch webinar on 27 May 2021 (5pm CET) with interesting presentations by the authors, esteemed commentators and moderated by Joseph Straus. See the flyer for the detailed program.

The Zoom webinar is free of charge. I understand that no pre-registration is needed. You can join directly via the ‘Registration now’ hyperlink here.

/ MW

The annual must-attend event on case-law of the FPC on Thursday, 12 March 2020

UPDATE 11 March 2020:

Struck by the bug: The event has been canceled due to COVID-19.

vespa.swiss

Don’t miss VESPA‘s annual evening seminar about recent case law of the FPC on Thursday, March 12 in Zurich; see the program below.

Gain first-hand insight from Tobias BREMI (second ordinary judge at the FPC) in the Haus zum Rüden, Limmatquai 42, 8001 Zurich; see map.

The event is free of charge for VESPA members; the fee for non-members is CHF 90,–. An apéro riche afterwards is offered for CHF 60,–.

Space is limited; please use the registration form below or save your spot online.

Reported by Martin WILMING

PROGRAM

Fullscreen view (new tab)

REGISTRATION FORM

Fullscreen view (new tab)

MAP

BE ON THE KNOW

Enter your name and email address below to get notified of new posts by email.